The Board of Directors of the i2b2 TranSMART Foundation has appointed David Dimond of Dell Technologies to the Board.

Dave is the Chief Innovation Officer and a Distinguished Engineer Emeritus for Dell Technologies Global Healthcare and Life Sciences business. Dave’s charter is to establish enduring customer and technical alliance partner collaborations to drive joint engineering, development, commercialization and delivery of data intensive cloud-based platforms for healthcare. He also leads new business development for healthcare human progress initiatives through a portfolio of unique platforms for social innovation.

Before joining Dell Technologies Dave was a strategic advisor to several healthcare ISVs, startups and investment banks while co-founding WhatNext, a social media platform for sharing patient experience aligned with the American Cancer Society and philanthropic organizations. Prior to this, he was the Senior Vice President of Product Innovation at Technology Solutions Company where he founded new lines of business including their healthcare solutions group while incubating medical imaging analytics product offerings.

Dave began his career in the healthcare industry at First Consulting Group where he became a Partner and served as a Vice President, a Technical Master V and a National Practice Director. He has authored numerous articles, technical papers, book chapters and technology courses during his extensive career. Dave has an MS in Engineering Management from Northeastern University and a BS in Electrical Engineering from the University of Massachusetts. He has served as an Adjunct Lecturer at the F.W. Olin Graduate School of Business at Babson College in the MBA program with a focus on the business of healthcare technology and analytics.

Dave is working with the GenNext Employee Resource Group within Dell Technologies to develop tools and novel methods for mass mentoring of diverse and young-in-career employees and also participates in Women in Action as a workshop developer.